论文部分内容阅读
Hexabrix 320(320mg l/ml)属低渗透压离子型造影剂。本研究通过30例冠状动脉造影及心血管造影(平均年龄:51.2岁,范围:39～65岁)评价Hexabrix 320的安全性及显影效果。所有病例在术前及术后(5″,15″)记录心率、心律,ECG,左室舒张末压及收缩压及主动脉压。由2名以上医生根据造影提供的显影质量及诊断信息来评价Hexabrix 320效果(评级为优、良、差)。本研究证明Hexabrix 320造影不引起病人ECG、血液动力学任何有意义的改变,无严重过敏反应,可以提供优良的冠状动脉及心血管影像及诊断。
Hexabrix 320 (320 mg l / ml) is a low-osmolar contrast agent. In this study, the safety and development of Hexabrix 320 were evaluated by coronary angiography and angiography in 30 patients (mean age: 51.2 years, range: 39-65 years). Heart rate, heart rate, ECG, left ventricular end-diastolic pressure and systolic pressure and aortic pressure were recorded in all cases before and after surgery (5 “, 15”). Hexabrix 320 results (rated excellent, good, bad) were evaluated by more than two doctors based on the quality of development and diagnostic information provided by the contrast. This study demonstrates that Hexabrix 320 angiography does not cause any meaningful changes in ECG and hemodynamics of patients and does not cause severe allergic reactions and can provide excellent coronary and cardiovascular imaging and diagnosis.